Side-Effect Management

Vitamin D May Reduce Immune Checkpoint Inhibitor–Related Colitis

By

Jonathan Goodman, MPhil

Vitamin D may be used to reduce the risk of immune checkpoint inhibitor-related colitis, as well as ulcerative colitis and graft-vs-host disease.

Exercise, Supportive Care Are Key to Managing Cancer-Related Fatigue in Patients With Cancer

By

Bette Weinstein Kaplan

Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.

Study Finds Vancomycin Increased Risk for Cytomegalovirus Reactivation After Hematopoietic Cell Transplant

By

Jessica Nye, PhD

A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.

High Prevalence of Urinary Incontinence With Breast Cancer Suggests Potential Overlap of Risk Factors

By

Rick Maffei

Researchers evaluated the prevalence, level, and impact on QOL of patient-reported urinary incontinence at baseline and after 3 months of systemic therapy.

Study Finds Higher Incidence of Atrial Fibrillation With Ibrutinib Therapy

By

Christina Bennett, MS

Patients with chronic lymphocytic leukemia who are treated with ibrutinib may have a higher incidence of atrial fibrillation than previously thought.

Loss of Limb Mobility in a Patient With T-ALL Treated With Nelarabine

By

Rick Maffei

In this patient case, significant neurological adverse effects associated with nelarabine were noted at 30 days following initiation of therapy.

Racial Disparities Seen in PET/CT Imaging for Lung Cancer

Black, Hispanic patients less likely to receive recommended imaging at time of diagnosis of NSCLC.

New ASCO Clinical Guidelines on Management of Cancer Cachexia

By

Caleb Rans

The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.

Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors

Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma.

Genetic Polymorphisms: Understanding Their Relationship With Pain and Treatment in Patients With Cancer

By

Vicki Moore, PhD

A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.